Location: | Dundee |
---|---|
Salary: | £36,024 to £44,263 Grade 7, per annum |
Hours: | Full Time |
Contract Type: | Fixed-Term/Contract |
Placed On: | 22nd March 2024 |
---|---|
Closes: | 22nd April 2024 |
Job Ref: | UOD1285 |
Division of Signal Transduction Unit (DSTT):
The Division of Signal Transduction Therapy (DSTT) was established in 1998. This division operates as a unique collaboration between scientists in the MRC PPU and signalling researchers at the University of Dundee’s School of Life Sciences (Simon Arthur, Doreen Cantrell, Aless io Ciulli, Ron Hay, Angus Lamond, Henry McSorley, Ignacio Moraga, Adrian Saurin) and three leading pharmaceutical companies (Boehringer Ingelheim, GlaxoSmithKline, Merck Serono). The DSTT is widely regarded as a model for how academia should interact with industry. The DSTT operates as a simple bridging mechanism to enable our PIs working on ubiquitylation and phosphorylation to effectively interact with three major pharm aceutical companies to help accelerate the early stages of drug discovery.
We are looking for an exceptional individual to join the Sapkota Lab as a Postdoctoral Research Assistant to investigate the molecular roles of the FAM83 family of proteins. We have found that FAM83 proteins are the master regulators of CK1 kinases, which themselves are critical for normal cell function and are dysregulated in many diseases, including cancer (PMID: 29789297). We have established that specific FAM83-CK1 interactions are key in controlling a variety of cellular processes ranging from WNT signalling (PMID: 29514862; 33361109; 33361334) to cell division (PMID: 31338967) and can play direct roles in disease pathology (PMID: 31656861).
Given the importance of FAM83-CK1 interactions, it is critical that we now understand the molecular basis of these and determine how specific FAM83 proteins deliver CK1 activity to specific substrates to control CK1 biology. We will employ cutting edge technologies, such as CRISPR/Cas9 genome editing, Cryo-EM & crystallography, mass- spectrometry, and organoid models, in this endeavour. Furthermore, the project aims to use PROTACs and molecular glue degraders to target the degradation of specific FAM83-CK1 complexes as an innovative strategy to inhibit cancer cell proliferation.
Your priorities will include:
Who we’re looking for:
For further information about this position please contact:
Gopal Sapkota at g.sapkota@dundee.ac.uk.
To find out more about MRC PPU please visit: https://www.ppu.mrc.ac.uk/
Type / Role:
Subject Area(s):
Location(s):